Leukaemia and Lymphoma Cancer Articles from Article Codex

What Is Lymphoma?

28/06/2007 03:40:21

Lymphoma can change your life and the loved ones
around you use the Lymphoma Information Portal to
help you deal and adjust to living with cancer,
visit now.

Rituxan Update � Two New Applications

28/01/2007 17:20:31

Genentech, Inc. and Biogen Idec, Inc. just announced that the FDA approved two additional uses for Rituxan (rituximab) for patients with CD20-positive, B-cell non-Hodgkin';s lymphoma (NHL).

Neuropathy or Sports-related Injury?

28/01/2007 17:20:02

Neuropathy is a painful condition caused by damaged nerves. It can cause a host of problems including dizziness, weakness, numbness to the extremities, and painful sensations like tingling and burning. It can also cause remittent soreness in the muscles of the legs and lower arms. It can be brief, last for years or never go away.

Lymphoma People Are Different

28/01/2007 17:19:34

One of the first things I noticed after being diagnosed with lymphoma is that my lymphoma compadres appear to be a little different from those with other cancers.

Green Tea Update

28/01/2007 17:19:03

I initially mentioned the subject of green tea in my March 31st blog, where I wrote about complementary medicines. Due to the large number of queries, I followed that up with another blog on April 24th, where I go into an in-depth explanation of the green tea extract that I included in my treatment plan for lymphoma.

Good News About Bexxar and Follicular Lymphoma

28/01/2007 17:18:34

Until three or four years ago, there weren';t a lot of treatment choices for lymphoma patients who relapsed or had their cancer transform into a more aggressive form of the disease. Fortunately, these patients have many more options today due to targeted therapies such as Rituxan (rituximab), vaccines, stem cell transplants and the radioimmunotherapies, Zevalin (ibritumomab) and Bexxar (tositumomab).

You Don';t Look Sick!

28/01/2007 17:07:07

Joy Selak knows what it is like to live with an "invisible" chronic illness. She went from hating it, to embracing it, to using it as a platform to help others. She teamed up with her doctor, Seattle rheumatologist Steven Overman, M.D., to write a wonderfully helpful book, "You Don';t Look Sick!: Living Well with Chronic Illness." Our dear host of HealthTalk Live, Judy Foreman, also interviewed them on the HealthTalk site. And I had a fascinating hour with them this past weekend as they joined me on my Patient Power radio show. The following is Joy';s story:

Who Is The FDA Trying To Protect?

28/01/2007 17:06:31

I';ll be the first to say the folks at the FDA have a hard job. It is their responsibility to protect the public safety and certainly not subject those of us who are ill to drugs that offer false hope or tremendous risk. And when it comes to considering new drugs for approval, I know how much they want to get it right the first time. The last thing they need is to have to pull a drug off the market after people have been hurt causing damage to the FDA';s credibility to Congress.

Looking Behind The FDA Curtain

28/01/2007 17:06:03

Thank you for all the comments to my blog postings about the FDA and its process for reviewing Genasense. It';s still up to the FDA to approve it or not. It is an uphill battle as the advisory committee voted 7-3 against approval. The earlier blog posting and the very expert comments from so many CLL';ers will provide you with a all the background if you are new to the discussion.

Genta Answers Our Questions About Genasense

28/01/2007 17:05:31

If you have been following this blog, you know I am on a campaign to get some answers from the FDA on how they evaluate potential new drugs. In this case, we are following the evaluation of a potential drug for my condition, CLL, and whether the evaluation is fair and based on the FDA and its outside consultants being conversant with the issues CLL patients and expert hematologists face every day. Basically, we are trying to a see if the process gives us patients appropriate opportunities to have potentially life-saving or life-extending drugs.